Endogenous opioids are known to mediate some of the cardiovascular seq
uelae of sepsis. Inhibition of adrenergic action has been implicated a
s a physiological path by which endogenous opioids cause deleterious c
hanges in cardiovascular function during endotoxin shock, but where an
d to what extent this accounts for changes in regional vascular resist
ance remains unclear. In this study, we addressed this question by exa
mining the role of alpha-adrenergic actions in cardiovascular performa
nce and the regional perfusion changes caused by naloxone during endot
oxin shock. Rats had catheters inserted into the tail artery, left car
diac ventricle, and jugular vein. Twenty-four hours later, rats receiv
ed saline or endotoxin (2 mg/kg) challenge intravenously over 30 min,
followed at 40 min by intravenous naloxone (or saline) treatment (4 mg
/kg + 2 mg/kg . h) in the presence or absence of phentolamine (100 mu
g/kg + 600 mu g/kg . h) or yohimbine (40 mu g/kg + 4 mu g/kg . h). Rad
iolabeled microspheres were used to determine cardiac outputs and bloo
d flows at 0, 30, 60, and 120 min after beginning endotoxin infusion.
Naloxone attenuated the endotoxin-induced decline in mean arterial pre
ssure (MAP) and cardiac output (GO), but had no effect on increased sy
stemic vascular resistance (SVR). Phentolamine blocked naloxone's abil
ity to increase MAP and CO, but permitted an increase in SVR by naloxo
ne. In the presence of yohimbine, naloxone still increased MAP, but no
t CO nor SVR. Regional vascular responses varied, with naloxone demons
trating a vasoconstrictive effect despite alpha-adrenergic receptor bl
ockade in some beds, and no effect in others. The response of individu
al organs in the hepatosplanchnic circulation was heterogenous as well
. These data suggest that some effects of endogenous opioids during en
dotoxin shock are mediated via inhibition of alpha-adrenergic effects,
but that some cardiovascular effects of endogenous opioids are indepe
ndent of adrenergic control during endotoxin shock.